| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $47.3M | +49.6% |
| Cost of Revenue | $11.1M | +52.6% |
| Gross Profit | $36.2M | +48.7% |
| R&D Expense | $7.7M | +72.2% |
| SG&A Expense | $54.8M | +58.7% |
| Operating Income | -$26.3M | -79.5% |
| Pre-tax Income | -$40.4M | -158.4% |
| Income Tax | $0 | — |
| Net Income | -$40.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.9M | +338.9% |
| Accounts Receivable | $8.3M | +61.4% |
| Inventory | $21.6M | +54.7% |
| Current Assets | $157.2M | +347.4% |
| Total Assets | $169.9M | +294.4% |
| Current Liabilities | $14.2M | +85.6% |
| Long-term Debt | $14.9M | +1.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.6M | -102.3% |
| Capital Expenditures | $7.4M | +84.5% |
| Investing Cash Flow | -$95.6M | -784.6% |
| Financing Cash Flow | $145.0M | — |
| Free Cash Flow | -$36.0M | -98.4% |
| -158.4% |
| EPS (Basic) | -$4.65 | +98.1% |
| EPS (Diluted) | -$4.65 | +98.1% |
| Total Liabilities |
| $29.2M |
| +25.1% |
| Stockholders' Equity | $140.8M | +357.3% |